Cytomégalovirus et grossesse : Risque fœtal et néonatal
(1992) Journal de gynécologie, obstétrique et biologie de la reproduction — Vol. 21, n° 7, p. 779-790 (1992)
Files
9590.pdf
Restricted Access - Adobe PDF
- 3.83 MB
Details
- Authors
- Abstract
- A review of the literature shows that 36% of pregnant women are not immunized against cytomegalovirus; 2.11% of these patients will have a primary infection during their pregnancy. The fetal transmission rate is 30%. Viruria after delivery is the unique proven sign of infection; but is only present in 4 to 5 infants per 1,000 births. Of those, 17% will be symptomatic at delivery and 10% will develop sequels as late as seven years later. CMV can be reactivated during pregnancy. These cases are less dangerous but the fetal risk is always present.
- Affiliations
Citations
Gaudy, V., Lamy, M. E., Mulongo, N. K., & Van Lierde, M. (1992). Cytomégalovirus et grossesse : Risque fœtal et néonatal. Journal de gynécologie, obstétrique et biologie de la reproduction, 21(7), 779-790. https://hdl.handle.net/2078.5/131985 (Original work published 1992)